What Happened?
San Francisco, CA-based Viz Appointed Chris Mansi as Chief Executive Officer
About the Company
In 2015, five seminal randomized controlled trials were published in the neurovascular space demonstrating endovascular thrombectomy to be the new gold standard for treating large vessel occlusion strokes. During that same year, advancements in artificial intelligence and deep learning made it possible to analyze medical imaging rapidly and accurately. However, despite having proven effective interventions for stroke, most stroke patients were getting treatment late or not at all. At Stanford University, Dr. Chris Mansi (neurosurgeon) and Dr. David Golan (machine learning researcher) identified this problem and together they sought to change it.
About the Person
Chris Mansi is Chief Executive Officer at Viz. Previously, Chris held various senior HR leadership roles in the industry.
Info Source
News
Short Profile